Cargando…

MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common human malignant tumors. The prognosis of HCC patients is still unsatisfying. Thus, it is of great importance to identify novel molecules and functional pathways associated with the pathophysiology of HCC. In this study, we performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Wei, Shen, Yu, Li, Quanxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547126/ https://www.ncbi.nlm.nih.gov/pubmed/33116820 http://dx.doi.org/10.2147/CMAR.S267493

Ejemplares similares

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Zhang, Chaohua, et al.
Publicado: (2023)

Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma
por: Pang, Shu-Jie, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
por: Wu, Zhenzhen, et al.
Publicado: (2022)

MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Chen, Dengwang, et al.
Publicado: (2023)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma
por: Han, Jiyu, et al.
Publicado: (2022)

Bioinformatics Analysis Reveals MCM3 as an Important Prognostic Marker in Cervical Cancer
por: Ma, Hui, et al.
Publicado: (2021)

Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Hui, et al.
Publicado: (2022)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation
por: Jia, Mingxi, et al.
Publicado: (2022)

MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma
por: Chen, Junyu, et al.
Publicado: (2023)

Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
por: Ding, Yuxi, et al.
Publicado: (2022)

Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation
por: Wang, Ningning, et al.
Publicado: (2021)

Identification of novel biomarkers in septic cardiomyopathy via integrated bioinformatics analysis and experimental validation
por: Lu, Feng, et al.
Publicado: (2022)

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis
por: Yang, Wan-Xia, et al.
Publicado: (2019)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

Integrated Bioinformatic Investigation of EXOSCs in Hepatocellular Carcinoma Followed by the Preliminary Validation of EXOSC5 in Cell Proliferation
por: Zhang, Yujing, et al.
Publicado: (2022)

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
por: Chen, Yanru, et al.
Publicado: (2022)

EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023)

Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis
por: Guo, Honglan, et al.
Publicado: (2021)

Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis
por: Tian, Siyuan, et al.
Publicado: (2023)

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018)

Juvenile Hormone-Receptor Complex Acts on Mcm4 and Mcm7 to Promote Polyploidy and Vitellogenesis in the Migratory Locust
por: Guo, Wei, et al.
Publicado: (2014)

Bioinformatic analyzes and validation of cystathionine gamma-lyase as a prognostic biomarker and related to immune infiltrates in hepatocellular carcinoma
por: Xiang, Jianfeng, et al.
Publicado: (2023)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance
por: Shi, Ke-Qing, et al.
Publicado: (2015)

Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Mapping ubiquitination sites of S. cerevisiae Mcm10
por: Zhang, Tianji, et al.
Publicado: (2016)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model
por: Zhou, Lei, et al.
Publicado: (2023)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis
por: Shen, Bo, et al.
Publicado: (2020)

Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation
por: Ren, Xinxin, et al.
Publicado: (2022)

Recruitment of Mcm10 to Sites of Replication Initiation Requires Direct Binding to the Minichromosome Maintenance (MCM) Complex
por: Douglas, Max E., et al.
Publicado: (2016)

Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
por: Zhao, Wenjing, et al.
Publicado: (2023)

SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation
por: Yue, Chaosen, et al.
Publicado: (2019)

Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma
por: Ran, Yunsheng, et al.
Publicado: (2023)

Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
por: Zhang, Qingquan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvuhvaiiivn9i6bj6i7t9dfvkf